New O O O O
to O O O O
MyHealth? O O O O
Manage O O O O
Your O O O O
Care O O O O
From O O O O
Anywhere. O O O O
Access O O O O
your O O O O
health O O O O
information O O O O
from O O O O
any O O O O
device O O O O
with O O O O
MyHealth. O O O O
You O O O O
can O O O O
message O O O O
your O O O O
clinic, O O O O
view O O O O
lab O O O O
results, O O O O
schedule O O O O
an O O O O
appointment, O O O O
and O O O O
pay O O O O
your O O O O
bill. O O O O
Abstract O O O O
Development Reason 4 O O
of Reason 4 O O
a Reason 4 O O
safe Reason 4 O O
and Reason 4 O O
effective Reason 4 O O
SARS-CoV-2 Reason 4 O O
vaccine Reason 4 O O
is Reason 4 O O
a Reason 4 O O
public Reason 4 O O
health Reason 4 O O
priority. Reason 4 O O
We Reason 4 O O
designed Reason 4 O O
subunit Reason 4 O O
vaccine Reason 4 O O
candidates Reason 4 O O
using Reason 4 O O
self-assembling Reason 4 O O
ferritin Reason 4 O O
Ferritin Reason 4 O O
is Reason 4 O O
an Reason 4 O O
attractive Reason 4 O O
nanoparticle Reason 4 O O
platform Reason 4 O O
for Reason 4 O O
production Reason 4 O O
of Reason 4 O O
vaccines Reason 4 O O
and Reason 4 O O
ferritin-based Reason 4 O O
vaccines Reason 4 O O
have Reason 4 O O
been Reason 4 O O
investigated Reason 4 O O
in Reason 4 O O
humans Reason 4 O O
in Reason 4 O O
two Reason 4 O O
separate Reason 4 O O
clinical Reason 4 O O
trials. Reason 4 O O
We O O O O
confirmed O O O O
proper O O O O
folding O O O O
and O O O O
antigenicity O O O O
of O O O O
spike O O O O
on O O O O
the O O O O
surface O O O O
of O O O O
ferritin O O O O
by O O O O
cryo-EM O O O O
and O O O O
binding O O O O
to O O O O
conformation-specific O O O O
monoclonal O O O O
antibodies. O O O O
After Reason 4 O O
a Reason 4 O O
single Reason 4 O O
immunization Reason 4 O O
of Reason 4 O O
mice Reason 4 O O
with Reason 4 O O
either Reason 4 O O
of Reason 4 O O
the Reason 4 O O
two Reason 4 O O
spike Reason 4 O O
ferritin Reason 4 O O
particles, Reason 4 O O
a Reason 4 O O
lentiviral Reason 4 O O
SARS-CoV-2 Reason 4 O O
titers Reason 4 O O
at Reason 4 O O
least Reason 4 O O
2-fold Reason 4 O O
greater Reason 4 O O
than Reason 4 O O
those Reason 4 O O
in Reason 4 O O
convalescent Reason 4 O O
plasma Reason 4 O O
from Reason 4 O O
COVID-19 Reason 4 O O
patients. Reason 4 O O
Additionally, Reason 4 O O
a Reason 4 O O
single Reason 4 O O
dose Reason 4 O O
of Reason 4 O O
S?C-Fer Reason 4 O O
elicited Reason 4 O O
significantly Reason 4 O O
higher Reason 4 O O
neutralizing Reason 4 O O
responses Reason 4 O O
as Reason 4 O O
compared Reason 4 O O
to Reason 4 O O
immunization Reason 4 O O
with Reason 4 O O
the Reason 4 O O
spike Reason 4 O O
receptor Reason 4 O O
binding Reason 4 O O
domain Reason 4 O O
(RBD) Reason 4 O O
monomer Reason 4 O O
or Reason 4 O O
spike Reason 4 O O
ectodomain Reason 4 O O
trimer Reason 4 O O
alone. Reason 4 O O
After Reason 4 O O
a Reason 4 O O
mice Reason 4 O O
immunized Reason 4 O O
with Reason 4 O O
S?C-Fer Reason 4 O O
exhibited Reason 4 O O
higher Reason 4 O O
neutralizing Reason 4 O O
titers Reason 4 O O
than Reason 4 O O
all Reason 4 O O
other Reason 4 O O
groups. Reason 4 O O
Taken Reason 5 O O
together, Reason 5 O O
these Reason 5 O O
results Reason 5 O O
demonstrate Reason 5 O O
that Reason 5 O O
multivalent Reason 5 O O
presentation Reason 5 O O
of Reason 5 O O
SARS-CoV-2 Reason 5 O O
spike Reason 5 O O
on Reason 5 O O
ferritin Reason 5 O O
can Reason 5 O O
notably Reason 5 O O
enhance Reason 5 O O
elicitation Reason 5 O O
of Reason 5 O O
neutralizing Reason 5 O O
antibodies, Reason 5 O O
thus Reason 5 O O
constituting Reason 5 O O
a Reason 5 O O
viable Reason 5 O O
strategy Reason 5 O O
for Reason 5 O O
single-dose Reason 5 O O
vaccination Reason 5 O O
against Reason 5 O O
COVID-19. Reason 5 O O
View O O O O
details O O O O
for O O O O
[DOI O O O O
10.1101/2020.08.28.272518](https://doi.org/10.1101/2020.08.28.272518) O O O O
View O O O O
details O O O O
for O O O O
